Correction of DMD in human iPSC-derived cardiomyocytes by base-editing-induced exon skipping
Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene. Previously,
we showed that adenine base editing (ABE) can efficiently correct a nonsense point …
we showed that adenine base editing (ABE) can efficiently correct a nonsense point …
CRISPR/Cas9-mediated miR-29b editing as a treatment of different types of muscle atrophy in mice
Muscle atrophy is the loss of skeletal muscle mass and strength in response to diverse
catabolic stimuli. At present, no effective treatments except exercise have been shown to …
catabolic stimuli. At present, no effective treatments except exercise have been shown to …
Role of targeted therapy in dilated cardiomyopathy: the challenging road toward a personalized approach
JAJ Verdonschot, MR Hazebroek, JS Ware… - Journal of the …, 2019 - Am Heart Assoc
Dilated cardiomyopathy (DCM) is characterized by LV (left ventricular) or biventricular
systolic dysfunction and dilation, not explained by abnormal loading conditions or coronary …
systolic dysfunction and dilation, not explained by abnormal loading conditions or coronary …
CRISPR and cardiovascular diseases
K Musunuru - Cardiovascular Research, 2023 - academic.oup.com
CRISPR technologies have progressed by leaps and bounds over the past decade, not only
having a transformative effect on biomedical research but also yielding new therapies that …
having a transformative effect on biomedical research but also yielding new therapies that …
AAV9 edits muscle stem cells in normal and dystrophic adult mice
CRISPR editing of muscle stem cells (MuSCs) with adeno-associated virus serotype-9
(AAV9) holds promise for sustained gene repair therapy for muscular dystrophies. However …
(AAV9) holds promise for sustained gene repair therapy for muscular dystrophies. However …
Life-long AAV-mediated CRISPR genome editing in dystrophic heart improves cardiomyopathy without causing serious lesions in mdx mice
Previous studies from others and us have demonstrated that CRISPR genome editing could
offer a promising therapeutic strategy to restore dystrophin expression and function in the …
offer a promising therapeutic strategy to restore dystrophin expression and function in the …
Developments in reading frame restoring therapy approaches for Duchenne muscular dystrophy
AFE Schneider, A Aartsma-Rus - Expert opinion on biological …, 2021 - Taylor & Francis
Introduction Exon skipping compounds restoring the dystrophin transcript reading frame
have received regulatory approval for Duchenne muscular dystrophy (DMD). Recently, focus …
have received regulatory approval for Duchenne muscular dystrophy (DMD). Recently, focus …
Common therapeutic advances for Duchenne muscular dystrophy (DMD)
A Salmaninejad, Y Jafari Abarghan… - International Journal …, 2021 - Taylor & Francis
Background and purpose: Duchenne muscular dystrophy (DMD), a lethal X-linked recessive
muscle dystrophy, is resulted in by different mutations including mostly frame-shifting gross …
muscle dystrophy, is resulted in by different mutations including mostly frame-shifting gross …
High-throughput methods for genome editing: the more the better
Y Huang, M Shang, T Liu, K Wang - Plant Physiology, 2022 - academic.oup.com
During the last decade, targeted genome-editing technologies, especially clustered
regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein (Cas) …
regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein (Cas) …
CRISPR gene editing in the kidney
NM Cruz, BS Freedman - American Journal of Kidney Diseases, 2018 - Elsevier
CRISPR is a nuclease guidance system that enables rapid and efficient gene editing of
specific DNA sequences within genomes. We review applications of CRISPR for the study …
specific DNA sequences within genomes. We review applications of CRISPR for the study …